Freenome
Backed by
Raised $254M Series E on Feb 15, 2024
Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages.
Staff Bioinformatics Research Engineer
Brisbane, California · Posted on Aug 5, 2025
Manager, Cost Accounting
Brisbane, California · Posted on Jul 28, 2025
Senior Development Scientist
Brisbane, California · Posted on Jul 21, 2025
Automation Engineer II
Brisbane, California · Posted on Jul 18, 2025
Future Consideration
Brisbane, California · Posted on May 28, 2025
Senior Director, Market Access
Brisbane, California · Posted on May 28, 2025
Explore similar companies to Freenome
Junction
Modernizing healthcare infrastructure.
Counsel Health
Physician-led, AI-enhanced medical advice.
Power
Connecting patients with clinical trials.
Fortuna Health
Helping consumers navigate Medicaid.
OpenEvidence
The leading medical information platform.
Orchid
Helping couples have healthy babies.
Headlight
Online therapy and mental health services.
Silna
Make care your primary focus.
Tandem Health
Medical notes that write themselves.